All posts by imreal

Dr. Andrew Frankel Accepts Invitation to Present At 2022 Multispecialty Aesthetic Conference


Andrew S. Frankel, M.D., F.A.C.S. has been invited to present at the Multispecialty Aesthetic Conference

Dr. Andrew Frankel, a board-certified and world-renowned facial plastic surgeon, will present alongside some of the brightest minds in the four cosmetic specialties.

It is important that my work is sympathetic to patients’ features, so the changes they see are true to their essence, and not a departure from their identity. I feel a successful outcome is one that creates balance and harmony between facial features, so the result looks natural.

Andrew S. Frankel, M.D., F.A.C.S. has been invited to present at the Multispecialty Aesthetic Conference (MAC) + 22 Petvenge. The MAC returns in 2022 with a specialized focus on the intersection between art and science. Dr. Frankel, a board-certified and world-renowned facial plastic surgeon, will present alongside some of the brightest minds in the four cosmetic specialties. As a medical professional with over twenty-five years of experience, extensive clinical research and published works, and stellar patient results, Dr. Frankel is uniquely positioned to collaborate with his peers during this curated event. Throughout Dr. Frankel’s presentation, he will provide actionable insight, specialized knowledge, and an inside look into his holistic approach. Dr. Frankel will speak at the Marriott Marquis in San Diego, California, during this three-and-a-half-day event from August fourth through the seventh.

MAC + 22 Petvenge will include four tracks, over three hundred sessions, and upwards of one-hundred exciting speakers. This immersive meeting of the minds contains presentations from the industry’s most experienced professionals in plastic surgery, facial plastic surgery, oculoplastic surgery, and dermatology. Facial plastic surgery is a constantly evolving field requiring continuous education and advanced knowledge. Throughout Dr. Frankel’s career, he has embraced innovation while serving the academic community as a clinical faculty member at the University of California Los Angeles and the University of Southern California Keck School of Medicine. In addition to authoring numerous clinical publications, Dr. Frankel acted as a principal investigator on two landmark FDA clinical trials. Dr. Frankel, a dual board-certified surgeon, prepares for a unique presentation combining his unparalleled clinical skills, world-class training, and immense passion for artistry. Interdisciplinary knowledge sharing and patient care improvements are of the utmost importance to Dr. Frankel.

Dr. Frankel is a pioneer in delivering surgical and non-surgical treatments, including injectables, neuromodulators, blepharoplasty, rhinoplasty, facial rejuvenation, contouring, facial lifts, otoplasty, dermal fillers, revision rhinoplasty, and buccal fat removal. Throughout the consultation, planning, and surgical processes, Dr. Frankel comes alongside his patients to create individualized care plans and empower them to achieve their goals. According to Dr. Frankel, “it is important that my work is sympathetic to patients’ features, so the changes they see are true to their essence, and not a departure from their identity. I feel a successful outcome is one that creates balance and harmony between facial features, so the result looks natural.” While serving his patients, Dr. Frankel continues to advance his knowledge as a fellow of the American College of Surgeons, an active member of the American Academy of Facial Plastic and Reconstructive Surgery, and the American Academy of Otolaryngology.

Dr. Frankel is one of the most prestigious facial plastic surgeons worldwide and provides exceptional care. Among his peers and patients, Dr. Frankel has a reputation for dedicating himself entirely to delivering world-class healthcare experiences for each patient. To register for MAC + 22 Petvenge and attend Dr. Frankel’s presentation, individuals can visit the following link. To schedule a consultation or learn more about Dr. Frankel’s practice, visit https://www.drandrewfrankel.com/about/dr-andrew-frankel.

Share article on social media or email:

Top NYC Plastic Surgeon, Dr. Aleksandr Shteynberg will be featured on WCBS’s “American Health Front” on Saturday, August 27th at 4pm


News Image

“This program provides a great opportunity for viewers to learn about 6-pack abdominal etching and mommy makeovers. I am looking forward to sharing it my expertise and experience with viewers who are interested in these types of procedures,” says Dr. Aleksandr Shteynberg.

Dr. Aleksandr Shteynberg, owner of Vantage Plastic Surgery, will be a on an upcoming episode of “American Health Front,” sharing his knowledge as a top medical expert on WCBS-TV, CBS. “American Health Front” is a medical news program produced by Medical Media Group based in Broomfield, Colorado. American Health Front is the longest-running medical news program on network television regarding American health and has been educating households across the country since 2002. On the broadcast, Dr. Shteynberg will provide his medical insight and skill to show two popular surgeries being done, an abdominal etching (or cosmetic etching) and a mommy makeover.

Abdominal etching is the process of using liposuction to create the appearance of a ‘permanent six-pack’ on their abs. The ideal candidate for abdominal etching is physically fit, with a few areas of belly fat, but cannot get the definition they desire even with regular workouts.

Dr. Shteynberg will also be discussing mommy makeovers for viewers, which is a customized combination of abdomen and breast plastic surgery procedures, designed to restore a youthful appearance to their body after the dramatic changes brought on by pregnancy, childbirth, and breastfeeding. The mommy makeover can also benefit patients who have undergone massive weight loss, or anyone looking to address multiple body areas at once.

“This program provides a great opportunity for viewers to learn about 6-pack abdominal etching and mommy makeovers. I am looking forward to sharing it my expertise and experience with viewers who are interested in these types of procedures,” says Dr. Aleksandr Shteynberg.

More about Dr. Aleksandr Shteynberg:

Dr. Aleksandr Shteynberg is a double board-certified plastic surgeon specializing in reconstructive and cosmetic surgery at his practice Vantage Plastic Surgery, located in Manhattan at 791 Park Avenue, Suite 1B. Vantage Plastic Surgery is a cutting-edge facility that is accredited by the American Association for Accreditation of Ambulatory Surgery Facilities (AAAASF). To schedule a consultation or for more information about Vantage Plastic Surgery, please call 212-951-1877, or visit the website at http://www.vantageplasticsurgery.com.

Share article on social media or email:

Delivering Patient Data through a Regulated Platform to Improve Trial Oversight, Upcoming Webinar Hosted by Xtalks


Sponsors and CROs can now review real-world insights, which can be further analyzed to identify trends, establish correlations with greater confidence and generate more actionable clinical insights.

Patient-centric designs allow users to better engage and participate in a familiar environment. The rapid growth of patient-centric trials has served as a catalyst for the development of new, minimally invasive ways to collect high-quality clinical patient data. This demand combined with the growing evidence around the benefits of automated data qualification and aggregated data streams, has empowered the accelerated growth of connected sensors and wearables in clinical research.

The result? Sponsors and CROs can now review real-world insights, which can be further analyzed to identify trends, establish correlations with greater confidence and generate more actionable clinical insights.

However, to deliver this potential, a unique blend of processes and technology is needed within a regulated and unified clinical platform.

Taking data streams through patient-centric design allows users to better engage and participate in a familiar environment and removes many of the manual steps in traditional research.

In this webinar, the featured panel of clinicians and technology leaders will discuss: How one can increase operational efficiencies and enhance the patient experience in clinical trials; Why the industry has moved towards patient-centric data collection; The benefits of a clinical platform approach over siloed solutions; How to use these best practices to drive future decision-making.

Join this webinar to learn about unlocking better patient outcomes, more actionable insights and enhanced real-world patient data through a regulated platform.

Join experts from Medable, Gillian Livock, SVP & GM Digital Measures; and Colin Weller, VP – Partner Technologies, for the live webinar on Wednesday, September 7, 2022, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Delivering Patient Data through a Regulated Platform to Improve Trial Oversight.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

ASHA Welcomes Final FDA Regulations for OTC Hearing Aids


With the U.S. Food and Drug Administration’s (FDA) final rule for over-the-counter (OTC) hearing aids now available, the American Speech-Language-Hearing Association (ASHA) is praising the agency for the landmark regulations intended to ensure the safety and effectiveness of this new class of direct-to-consumer medical devices.

“ASHA fully supports the creation of this new category of over-the-counter hearing devices, which will increase the availability and affordability of hearing aids for many Americans,” said Janice R. Trent, AuD, CCC-A, Vice President for Audiology Practice for ASHA’s Board of Directors. “It is important the public understands these devices are only for adults with perceived mild to moderate hearing loss, and to strongly consider getting a hearing assessment by a certified audiologist as a first step before they purchase anything.”

Hearing loss is a serious and complex medical condition that can affect a person’s overall health, physical safety, and quality of life. ASHA stresses that—although many people will be helped by OTC hearing aids—for others, a device alone will not be the most effective solution. Audiologists—trained health care professionals who provide patient-centered care in the prevention, identification, diagnosis, and treatment of hearing, balance, and other auditory disorders—will continue to be crucial partners for consumers as they seek help with their hearing issues, which can vary considerately—and, therefore, require various forms of care.

ASHA Comments, Concerns

ASHA submitted comments to the agency on its draft regulations for OTC hearing aids in January 2022. The Association emphasized the need for safety—and strongly recommended that consumers obtain a hearing assessment before purchasing an OTC hearing aid. Such assessments are generally covered by insurance, even if follow-up treatment and/or hearing aids are not. Many people underestimate the severity of their hearing loss. Additionally, an assessment can help rule out other medical issues that may be causing a person’s hearing loss, ranging from earwax buildup to a tumor.

ASHA is still in the process of carefully reviewing the FDA’s final rule—which will take some time. Upon initial review, ASHA remains pleased with the majority of the included provisions. The output limit has been lowered to 111 dB SPL, or 117 dB SPL if the device is equipped with activated input-controlled compression, and devices are required to have a user-adjustable volume control. Additionally, device insertion depth has been more clearly defined (the device must remain 10 mm or greater from the tympanic membrane), and the language used in the warnings and other important information that shall appear outside and inside the packaging has been simplified.

ASHA’s comments also urged the FDA to clarify the effect of the rule on state laws requiring audiological evaluations. In response, the agency confirmed that the final rule does not preempt state laws requiring an audiological evaluation for minors, nor does it preempt other previously granted state exemptions applicable to non-OTC hearing aids.

However, ASHA does remain concerned that the final regulations do not contain a gain limit and that there is little to no mention of the benefit of seeking consultation from an audiologist prior to the purchase of any hearing aid.

ASHA Educational Resources

To help inform and protect consumers, ASHA has created a new Over-the-Counter Hearing Aid Toolkit. It is mainly intended for audiologists, primary care physicians, and pharmacists—to provide to their patients and customers. These professionals likely will be fielding the most questions on OTC hearing aids from people concerned with their hearing. The toolkit includes resources such as FAQs, hearing checklists, and more. Additionally, ASHA is forging partnerships with allied professional groups to educate the public.

Note to Reporters: For questions about ASHA’s position on OTC hearing aids, or to schedule an interview with an audiology expert, please contact ASHA Public Relations at pr@asha.org.

About the American Speech-Language-Hearing Association (ASHA)

ASHA is the national professional, scientific, and credentialing association for 223,000 members and affiliates who are audiologists; speech-language pathologists; speech, language, and hearing scientists; audiology and speech-language pathology support personnel; and students. Audiologists specialize in preventing and assessing hearing and balance disorders as well as providing audiologic treatment, including hearing aids. Speech-language pathologists (SLPs) identify, assess, and treat speech, language, and swallowing disorders. http://www.asha.org

View all ASHA press releases at https://www.asha.org/about/press-room/.

Share article on social media or email:

Picis Announces Multi-Year, Multi-Facility Agreement with Fraser Health


News Image

“The addition of Fraser Health further supports consistent reporting across multiple health authorities and reinforces the proven reliability of Picis Anesthesia Manager.”

Picis Clinical Solutions, Inc. (Picis) is pleased to announce that Fraser Health Authority, located in British Columbia, Canada, has selected the Picis suite of solutions to enhance their existing EHR solution. The implementation of Preop Manager, Anesthesia Manager and PACU Manager across the Health Authority in 11 acute hospital facilities including all 90 operating rooms to help maintain a contiguous record of the patient perioperative journey.

Picis’ solutions are completely integrated with Meditech and allow for comprehensive system reporting that will provide valuable insight across all of Fraser Health. The project will include implementation of perioperative software with both the Meditech Client/Server and the Meditech Expanse platforms as facilities deploy the new Meditech solution.

Vice President of Sales and Marketing, Chris Lamont stated, “We are proud to expand the Picis footprint within the province of British Columbia. The addition of Fraser Health further supports consistent reporting across multiple health authorities and reinforces the proven reliability of Picis Anesthesia Manager.”

To learn more about Picis solutions, visit http://www.picis.com.

ABOUT PICIS:

Picis Clinical Solutions (Picis) is a global provider of clinical information solutions that automate the entire perioperative experience with one continuous patient record, from preop to anesthesia through PACU. Picis continues to focus and specialize the integrated suite of solutions in life-critical areas of the hospital where the patients are the most vulnerable and the care process is the most complex. The software enables rapid, sustained delivery of clinical documentation, and financial and operational results. From department performance to patient case costing, hospitals benefit from the ability to interact with the data needed to help clinicians improve patient care, engagement and satisfaction. Picis Clinical Solutions, a wholly owned subsidiary of N. Harris Computer Corporation, provides licensed systems for use at more than 400 hospitals worldwide.

Share article on social media or email:

RevCycle Partners Eligibility Verification Service Now Supports Crystal PM


Paul Hartge, CEO of RevCycle Partners.

WeVerify is designed to give practice staff an immediate picture of the benefits available for each patient two days before the visit for vision and medical payers.

WeVerify, RevCycle Partners’ eligibility, and verification service, now supports Crystal PM, a leading practice management and EHR software provider.

WeVerify is designed to give practice staff an immediate picture of the benefits available for each patient two days before the visit for vision and medical payers. For many eyecare practices, patient benefits verification before the visit is an incomplete process or perhaps not done at all.

“Adding support for Crystal PM is an important milestone,” says Paul Hartge, CEO of RevCycle Partners, “in our strategy to offer WeVerify across a wide range of practice management software. A key aspect of WeVerify is placing verified benefits data in the most impactful areas of a practice’s PMS. By tailoring our solution to Crystal PM, we are able to accomplish that objective.”

At least two days before a patient visit, WeVerify collects the benefits data for each patient and provides detailed benefits information, visible through the PMS. One significant benefit of WeVerify is the new revenue opportunities for the practice. The service identifies unused benefits for additional services and eyewear.

In addition, WeVerify enables the practice to collect upfront the correct co-pay, eliminating billing and collections headaches. WeVerify, ultimately, helps eyecare practices build trust with patients through benefits transparency.

“I think it is an amazing system for an office that does not have the staff or the training to verify the medical insurance,” says Heather Morris Vyhovsky, Practice Administrator of Littlefield Eye Associates. “It saves a lot of time if you bill medically. WeVerify has it done before the patient arrives.”

RevCycle Partners was originally started as a billing service of RevolutionEHR, the leading cloud-based software for optometrists, but in 2018, RevCycle Partners separated from RevolutionEHR and formed an independent company.

Today, RevCycle Partners is one of the largest revenue cycle management companies in the optometric industry, serving hundreds of practices across the United States on all the major software platforms with its billing, credentialing, and eligibility services.

WeVerify pricing is tiered, based on the number of monthly patient verifications. For information on pricing, visit https://revcycle-partners.com/optometry-rcm-services/weverify/. For media inquiries, contact Kirsten Tangeros at kirsten@czstrategy.com.

Share article on social media or email:

CS Analytical Expands Service Offering With USP 1663 & USP 1664 Extractable & Leachable Testing


USP 1663 & USP 1664 | Extractable & Leachable Testing

Adding E&L testing now enables CS Analytical to offer a full spectrum of package system qualification services across the entire package system lifecycle

CS Analytical Laboratory, the world’s only FDA regulated contract laboratory exclusively dedicated to providing regulatory solutions and qualification testing services specifically for drug product and medical device container systems, is pleased to announce a new service offering specific to USP 1663 Extractable testing and USP 1664 Leachable testing. E&L program requirements play a critical role in the overall evaluation of package system components and their interaction with the drug products they are designed to hold. Drug efficacy and patient safety are at the core of these types of studies.

“The addition of USP 1663 and USP 1664 extractable and leachable testing services is a natural progression to the current USP container and package system qualification work that the CS Team currently performs. Adding E&L testing now enables CS Analytical to offer a full spectrum of package system qualification services across the entire package system lifecycle,” noted Brian Mulhall, CEO of CS Analytical.

The FDA and other regulatory agencies have defined clear guidelines for E&L requirements. Manufacturers are expected to know and understand the potential chemical interactions between the drug product and the package system. While USP 661.1 and USP 661.2 provide a basic extraction profile and are required for routine qualification, in many cases these may not be enough to satisfy E&L regulatory requirements. USP 1663 Extractables studies are designed to identify “substances” in a container closure system that can be “extracted” or pulled out of the components under conditions of stress. As defined under USP 1664, leachables are substances, or chemicals, that come out, or “leach” from, the package system components under normal use conditions. A comprehensive E&L program will include method development, method validation, materials characterization, impurity identification and elemental impurities analysis. A toxicological assessment also plays a crucial role in determining a safety profile score. A variety of laboratory instrumental techniques may also be used and may include HPLC, LC.MC, ICP, NMR, GC/MS.

About CS Analytical Laboratory

The only FDA regulated, cGMP laboratory dedicated exclusively to the complex world of drug and medical device container and package qualification testing, the CS Analytical Team includes the world’s leading experts on all relevant USP and EP requirements and the thought leaders and pioneers on CCI (container closure integrity – CCI) testing. Offering a full suite of laboratory services to include all USP, EP and JP procedures specific to glass, plastic and elastomers as well as complete USP 1207 services that span basic feasibility studies, component qualification programs and advanced method development and validation for helium leak testing, vacuum decay, high voltage and headspace analysis leak testing. CS Analytical is the one source that can ensure your medical product container and package system meets the strict and complex regulatory requirements.

Share article on social media or email:

A Caribbean Perspective” offers an engaging look at the rites surrounding baptism


News Image

“Baptism, Superstitions, and the Supernatural: A Caribbean Perspective”: a thoughtful example of comparative religion research. “Baptism, Superstitions, and the Supernatural: A Caribbean Perspective” is the creation of published author Lesley George Anderson, a retired Methodist minister of the Methodist Church in the Caribbean and the Americas (MCCA) and a former president of the United Theological College of the West Indies (UTCWI), Kingston, Jamaica, where he previously served as Methodist warden and lecturer in philosophy and systematic theology. Anderson has twice been chair of the presidium of the Caribbean Conference of Churches (CCC), served the British Methodist Church Overseas Division as area secretary for the Americas, Caribbean, and Europe for eight years, served two terms as a member of the World Council of Churches (WCC) consultative group with Pentecostals, and was twice president (bishop) of the Panama/Costa Rica District Conference as well as president of the Belize/Honduras District Conference. He holds a Dip. Min. from the United Theological Seminary (UTS), now UTCWI, a BA from the University of London, a Cambridge Certificate in Religious Knowledge (CCRK) from the University of Cambridge, a MTh from the University of Oxford, a MA and ThM from Princeton Theological Seminary, and a MEd and EdD from Teachers College, Columbia University. He was honored as a distinguished alumnus of the latter institution in 2010.

Anderson shares, “the sacrament of baptism is undoubtedly to this day an exceedingly controversial sacrament of the Christian Church. The continuing differing debates, arguments, and views about adult (believers’) versus infant baptism are examined. Superstitions and the supernatural associated with this sacrament are given adequate attention in addition to the many other informative factors relating to this sacrament. Further, this sacrament is examined as a scriptural, psychological, theological, and social reality.

“The introduction of baptism as a liturgical phenomenon highlights the educational quality of this book as it takes the reader into the interesting and fascinating areas of baptism of blood, baptism by fire, baptism of the dead, baptism of the Holy Spirit, and baptism in the name of Jesus only. In addition, this book brings to the fore an intrinsic excitement and understanding about the symbols and symbolisms, images and mysteries, signs and wonders associated with this sacrament. The role of the Holy Spirit and the centrality of Jesus in the baptismal act are of importance recognized.

“If symbolically baptism means dying to sin and rising to new life with Christ, does this apply only to adult believers? This book explores the question against the background of research conducted in the Central American country of Belize that unearthed the views and beliefs of laypersons. The reach of the work extends beyond Belize, and Methodist traditions are compared with contrasting beliefs and practices of other denominations. Popular superstitions associated with baptism are also explored as well as the impact of African cultural practices on Christian theology in the lived experience of Caribbean peoples.

“Although this research was conducted in Belize, it is borderless and boundless. Of vital interest is the exploration of this sacrament in African religious beliefs and cultural practices. According to Professor Neville Duncan, former director of the Sir Arthur Lewis Institute of Social and Economic Studies at the University of the West Indies, Mona, Jamaica, the book is ‘theologically and sociologically stimulating…while written from the Methodist perspective…the issues raised will resonate with all Christian denominations.’ All denominations noted in this book are given their due respect regardless of their beliefs and/or baptismal practices.”

Published by Christian Faith Publishing, Lesley George Anderson’s new book offers a fine balance of religious and cultural influences regarding the baptism ritual.

Anderson offers readers a carefully researched and articulate discussion that will present a unique and respectful perspective on a variety of cultures around the world.

Consumers can purchase “Baptism, Superstitions, and the Supernatural: A Caribbean Perspective” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Baptism, Superstitions, and the Supernatural: A Caribbean Perspective,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

BIOLYTE Ranks No. 605 on the 2022 Inc. 5000 Annual List


BIOLYTE

BIOLYTE is the world’s first hydration drink that offers the same benefits as an IV bag. One bottle includes 6.5 times the electrolytes as other leading sports drinks, with 1/3 of the sugar – an efficient and effective remedy to severe dehydration and associated symptoms.

Inc. revealed that BIOLYTE is No. 605 on its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. The list represents a one-of-a-kind look at the most successful companies within the economy’s most dynamic segment—its independent businesses. Facebook, Chobani, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

“The significance of being named in the top 1,000 companies on the Inc. 5000 list is hugely impactful for BIOLYTE and our continued growth,” shares CEO Jesslyn Rollins. “We’re honored to be among an inspiring list of industries and rising businesses, and this award will further our goals of sharing the positive effects of BIOLYTE with as many people across the country as possible.”

The companies on the 2022 Inc. 5000 have not only been successful, but have also demonstrated resilience amid supply chain woes, labor shortages, and the ongoing impact of Covid-19. Among the top 500, the average median three-year revenue growth rate soared to 2,144 percent. Together, those companies added more than 68,394 jobs over the past three years.

Complete results of the Inc. 5000, including company profiles (with one on BIOLYTE) and an interactive database that can be sorted by industry, region, and other criteria, can be found at http://www.inc.com/inc5000. The top 500 companies are featured in the September issue of Inc. magazine, which will be available on August 23.

“The accomplishment of building one of the fastest-growing companies in the U.S., in light of recent economic roadblocks, cannot be overstated,” says Scott Omelianuk, editor-in-chief of Inc. “Inc. is thrilled to honor the companies that have established themselves through innovation, hard work, and rising to the challenges of today.”

BIOLYTE is the world’s first hydration drink to offer the same benefits as an IV bag. Developed by anesthesiologist and IV specialist Dr. Luther “Trey” Rollins, one bottle of BIOLYTE includes 6.5 times the electrolytes as other leading sports drinks, with 1/3 of the sugar – an efficient and effective remedy to severe dehydration and associated symptoms. BIOLYTE has recently added thousands of retail locations to its list of sellers and is now available in 21 total states and growing. Also find BIOLYTE on http://www.drinkbiolyte.com and on Amazon.

Share article on social media or email: